Powering the AI era of privacy-first activation to drive real-world health outcomes.
Location: United States
Total raised: $26M
Investors 1
| Date | Name | Website |
| 04.07.2025 | Swift Vent... | swift.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.05.2026 | Series A | $26M | FCA Ventur... |
Mentions in press and media 10
| Date | Title | Description |
| 14.05.2026 | BranchLab Secures $26M Series A: AI Transforms Pharma Commercialization | BranchLab finalized a $26 million Series A funding round. McKesson Ventures led the investment, boosting total funding to $35 million. This capital propels BranchLab’s advanced AI platform. It revolutionizes pharmaceutical commercialization... |
| 13.05.2026 | BranchLab: $26 Million Series A Raised To Expand AI Platform For Pharma Commercialization | BranchLab announced a $26 million Series A financing round led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures. The financing brings the company’s total funding to $35 million. The compa... |
| 13.05.2026 | BranchLab Raises $26M in Series A Funding | BranchLab, a Boulder, CO-based provider of an AI platform supporting healthcare commercialization, raised $26M in Series A funding. The round was led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and A... |
| 13.05.2026 | QuartzBio Receives Growth Investment from Eir Partners | QuartzBio, a Baltimore, MD-based life science technology company delivering portfolio‑scale sample and biomarker intelligence for clinical‑stage biopharma, received a growth investment form Eir Partners. The amount of the deal was not discl... |
| 09.09.2025 | Next Ventures Invests in BranchLab to Drive AI in Precision Healthcare | Next Ventures, a venture capital firm dedicated to advancing whole-person health, today announced a strategic investment in BranchLab, a provider of AI-native solutions for healthcare marketing. The investment underscores Next Ventures’ com... |
| 08.09.2025 | BranchLab Receives Investment from Next Ventures | BranchLab, a NYC-based provider of AI-native solutions for healthcare marketing, received an investment from Next Ventures. The amount of the deal was not disclosed. The company intends to use the funds to expand operations and its developm... |
| 18.07.2024 | Causal IQ Launches Groundbreaking 'ID-less' Healthcare Audience Solution | In Partnership with BranchLab, Causal IQ Introduces a Revolutionary Privacy-Focused Approach to Healthcare Advertising LOS ANGELES, July 18, 2024 /PRNewswire/ -- Causal IQ, a leading provider of advanced digital advertising solutions, annou... |
| 18.07.2024 | Causal IQ Launches ‘ID-less’ Healthcare Audience Solution | Causal IQ, a leading provider of advanced digital advertising solutions, announces the launch of its innovative ‘ID-less’ healthcare audience solution. This novel healthcare advertising solution leverages a strategic partnership with Branch... |
| 07.06.2024 | BranchLab Raises Seed Funding Round | BranchLab, a NYC-based data science company developing advanced AI software that enables healthcare brands to reach the right consumers, raised an undisclosed amount in Seed funding. The round led by newark venture partners with participati... |
| - | BranchLab | “Powering the AI era of privacy-first activation to drive real-world health outcomes.” |